Table 1 Baseline clinical characteristics of all participants
Characteristics | Control (n = 126) | ACS patients (n = 139) | P value |
|---|---|---|---|
Age | 51.40 ± 7.27 | 51.55 ± 6.60 | 0.854 |
Gender (female/male) | 63/63 | 69/70 | 0.953 |
Smoking | |||
Yes | 64 | 69 | 0.851 |
No | 62 | 70 | |
Drinking | |||
Yes | 58 | 65 | 0.905 |
No | 68 | 74 | |
TC (mmol/L) | 4.67 ± 0.47 | 4.74 ± 0.90 | 0.436 |
TG (mmol/L) | 1.36 ± 0.56 | 1.37 ± 0.64 | 0.895 |
LDL (mmol/L) | 2.52 ± 0.487 | 2.60 ± 0.57 | 0.163 |
HDL (mmol/L) | 1.40 ± 0.60 | 1.29 ± 0.42 | 0.083 |
vWF (ng/mL) | 4.55 ± 1.40 | 7.99 ± 1.71 | < 0.001 |
H-FABP (ng/mL) | 4.50 ± 1.33 | 22.04 ± 4.09 | < 0.001 |
TNF-α (ng/L) | 10.17 ± 3.13 | 25.93 ± 5.78 | < 0.001 |
IL-1β (ng/L) | 9.67 ± 4.77 | 27.52 ± 7.64 | < 0.001 |
IL-6 (ng/L) | 8.85 ± 4.24 | 28.00 ± 6.64 | < 0.001 |